Larimar Therapeutics, Inc. · NASDAQ:LRMR
Celano Michael bought 18,460 Larimar Therapeutics, Inc. shares (Form 4)
Traded Nov 11, 2026 · Filed Nov 12, 2026
On Nov 11, 2026, Celano Michael (Chief Financial Officer) bought 18,460 Larimar Therapeutics, Inc. shares at US$2.71 for US$49,992, leaving 234,245 shares. Filed Nov 12, 2026 (Form 4).
- Bought
- 18,460 shares
- Price
- US$2.71
- Value
- US$49,992
- Holding after
- 234,245 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Common Stock | Buy | 18,460 | US$2.71 | 234,245 | Direct |
Source
Download original · View original at SEC